Telapristone Acetate
N/A
Report date: 2026/05/02 20:00:18
NME
Base Information
Drug NameTelapristone Acetate
Drug Alias Name +[10]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[9]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesRepros Therapeutics IncNorthwestern University
Active IndicationsN/A
Inactive Indications +[9]